Pelthos Therapeutics Q2 EPS $(5.38) Beats $(6.26) Estimate
Benzinga Newsdesk 1 year ago
EarningsEarnings BeatsNews
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Pelthos Therapeutics (AMEX:PTHS) reported quarterly losses of $(5.38) per share which beat the analyst consensus estimate of $(6.26) by 14.06 percent. This is a 75.24 percent decrease over losses of $(3.07) per share
Pelthos Therapeutics (AMEX:PTHS) reported quarterly losses of $(5.38) per share which beat the analyst consensus estimate of $(6.26) by 14.06 percent. This is a 75.24 percent decrease over losses of $(3.07) per share from the same period last year.
